Clinical Observation Of Bu Qi Yang Xue Formula On Treating The Qi And Blood Deficiency Type Of Postpartum Hypogalactia

Objective：Preliminary evaluation by clinical observation side of qi and bloodqi and blood postpartum hypogalactia the therapeutic effect andsafety of clinical application for traditional Chinese medicineprescription data support and scientific basis to improvebreastfeeding rates.Methods：Collection of Chinese medicine hospital in Garden Hill Instituteof Obstetrics and Gynecology, First Hospital of Wuhan of HubeiProvince obstetric diagnosis of post-Queru syndromes of qi andblood of80patients (all treatment group). To three days postpartummedication, one a day, morning and evening taking medication for7days for a course of treatment. Medication during the observationof signs and symptoms of each patient before and after treatmentto improve the situation before taking after discontinuation, thepatient’s vital signs, blood, urine, stool, liver function, renalfunction, electrocardiogram, prolactin, estradiol, milk yield andother indicators of change. Result：1.Queru symptom efficacy: a total of80patients were cured26cases,effective in43cases,11cases, total effective rate was86.25%2.Comprehensive effect: cure rate was22.50%, effective rate is42.50%, the effective rate of36.25%, total effective rate was91.25%. Compare before and after treatment symptom scores, P <0.05,significant difference statistically significant; the Querusymptom scores before and after treatment comparison, P <0.05,significant difference was statistically significant; breakdown ofwhich also have significantly improved.3.Laboratory examinations indicators change: prolactin contentbefore treatment298.50±31.12ug/l, after treatment357.40±37.43ug/l, P>0.05, estradiol levels before treatment123.10±29.06pg/ml, after treatment58.85±12.68pg/ml, P>0.05, notstatistically significant, other auxiliary examination andtreatment after RBC, HGB, PLT although have change, but P>0.05,no significant difference.4.Affect therapeutic factors: age and efficacy P>0.05, suggestingthat age and no significant difference in efficacy, indicating thatthe clinical efficacy and age are not directly related. Conditionand efficacy, P <0.05, severity, and clinical efficacy significantdifference in the efficacy of the mild slightly better than severeillness. Mode of delivery and efficacy, P>0.05, suggesting thatmode of delivery with no significant difference in efficacy,indicating not directly related to the clinical efficacy and modeof delivery.5. Safety evaluation: observation of the clinical effects oftaking the medicine, the Chinese medicine treatment of all maternal without exception, no significant adverse reactions to the drug andallergy. Safety indicators before and after treatment (coagulation,three conventional, liver and kidney function, ECG, etc.), nosignificant changes are basically within the normal range. Insummary prompted qi nourishing party taking the safe and reliablemode of administration and dose clinical observation.Concludes：The Chinese proprietary qi and blood in order to effectively treatblood weak post-Queru, can significantly improve maternal breastdegree of filling, the amount of milk Queru extent, improvingmaternal lassitude, loss of appetite, Koushi white with symptoms,clinical application is safe and effective, non-toxic side effects.